""
JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis 3 years ago
THE ASTHMA SOCIETY CHALLENGES YOU TO ‘TAKE A BREATH’ WITH THEM THIS ST PATRICK’S WEEKEND 17-20TH MARCH 3 years ago
